ReviewFrontiers in immunology2021

Re-Programming Autoreactive T Cells Into T-Regulatory Type 1 Cells for the Treatment of Autoimmunity.

Patricia Solé et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.